72. McIntosh D, Kutcher S, Binder C, Levitt A, Fallu A, Rosenbluth M. Adult ADHD and comorbid depression: A consensusderived diagnostic algorithm for ADHD. Neuropsychiatric Disease and Treatment 2009;5:137-50.
84. Stahl SM, Pradko JF, Haight BR, Modell JG, Rockett CB, Learned-Coughlin S. A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Primary Care Companion to The Journal of Clinical Psychiatry 2004;6:159-66.
97. Grunhaus L, Dannon PN, Schreiber S, et al. Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study. Biological psychiatry 2000;47:314-24.
73. Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). European Archives of Psychiatry and Clinical Neuroscience 2006;256:i26-i31.
85. Demyttenaere K, and Liesbeth Jaspers. Review: Bupropion and SSRI-induced side effects. . Journal of Psychopharmacology, 2008;22:792804.
74. Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet (London, England) 2012;379:1045-55.
86. Andrade C, Sandarsh S, Chethan KB, Nagesh KS. Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms. The Journal of clinical psychiatry 2010;71:1565-75.
98. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. International Journal of Neuropsychopharmacology 2002;5:73-103.
76. Cuijpers P, van Straten A, Warmerdam L, Andersson G. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety 2009;26:279-88. 77. IsHak WW, Ha K, Kapitanski N, et al. The impact of psychotherapy, pharmacotherapy, and their combination on quality of life in depression. Harvard review of psychiatry 2011;19:277-89. 78. Pampallona S, Bollini P, Tibaldi G, Kupelnick B, Munizza C. Combined pharmacotherapy and psychological treatment for depression: a systematic review. Archives of general psychiatry 2004;61:714-9. 79. Pagnin D, de Queiroz V, Pini S, Cassano GB. Efficacy of ECT in depression: a meta-analytic review. Focus 2008;6:155-62. 80. Efficacy and safety of electroconvulsive therapy in depressive disorders: a systematic review and meta-analysis. Lancet (London, England) 2003;361:799-808. 81. Sérlyfjaskrá. at https://www.serlyfjaskra.is/ 82. Unipolar major depression in adults: Choosing initial treatment. 2016. 2017, at https:// www.uptodate.com/contents/unipolarmajor-depression-in-adults-choosing-initialtreatment?source=see_link#H51.) 83. Gunnell D, Julia Saperia, and Deborah Ashby. Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA’s safety review. BMJ (Clinical research ed) 2005;330:385.
88. Jefferson JW. A review of the cardiovascular effects and toxicity of tricyclic antidepressants. Psychosomatic Medicine 1975;37:160-79. 89. Philip Cowen PH, Tom Burns. Shorter Oxford Textbook of Psychiatry. 6 ed: Oxford University; 2012. 90. Gaster B, Holroyd J. St John’s wort for depression: a systematic review. Archives of Internal Medicine 2000;160:152-6. 91. Williams JW, Mulrow CD, Chiquette E, Noël PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary: clinical guideline, part 2. Annals of internal medicine 2000;132:743-56. 92. Magnús Blöndahl Sighvatsson HK, Engilbert Sigurðsson, Jón Friðrik Sigurðsson. Gagnsemi hugrænnar atferlismeðferðar við lyndis- og kvíðaröskunum hjá fullorðnum. Læknablaðið 2011;11. 93. Beck AT. Cognitive therapy and the emotional disorders. New York 1976. 94. Erikssonr EBS, Kristjánsdóttir H, Sigurðsson JF, Agnarsdóttir A, Sigurðsson E. Áhrif þunglyndislyfja og róandi lyfja á árangur af ósértækri hugrænni atferlismeðferð hópa í heilsugæslu. Læknablaðið 2013. 95. Meðferð þunglyndis og viðbrögð við sjálfsvígshættu. 2009. 2017, at http://www. landlaeknir.is/um-embaettid/greinar/grein/ item16405/Medferd-thunglyndis-ogvidbrogd-vid-sjalfsvigshaettu.) 96. Raflækningar leiðbeiningar fyrir notendur. 2010. at www.landspitali.is/lisalib/getfile. aspx?itemid=25321.)
100. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. Journal of affective disorders 2005;88:255-67.
21
87. Lunn M, Hughes RA, Wiffen PJ. Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia. The Cochrane Library 2014.
101. Daban C, Martinez-Aran A, Cruz N, Vieta E. Safety and efficacy of Vagus Nerve Stimulation in treatment-resistant depression. A systematic review. Journal of Affective Disorders 2008;110:1-15. 102. Kennedy SH, Giacobbe P, Rizvi SJ, et al. Deep brain stimulation for treatment-resistant depression: follow-up after 3 to 6 years. American Journal of Psychiatry 2011;168:50210. 103. Engilbert Sigurðsson ÞÓ, Magnús Gottfreðsson. Hver eru viðhorf Íslendinga til þunglyndislyfja og hvaða þættir ráða mestu um mótun þeirra? Læknablaðið 2006;62:374-6. 104. Lawlor DA, Hopker SW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials. BMJ (Clinical research ed) 2001;322:763. 105. Daley A. Exercise and depression: a review of reviews. Journal of Clinical Psychology in Medical Settings 2008;15:140. 106. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. Am J Psychiatry 2000;157:229-33. 107. Okuda A, Suzuki T, Kishi T, et al. Duration of untreated illness and antidepressant fluvoxamine response in major depressive disorder. Psychiatry and clinical neurosciences 2010;64:268-73.
Vörulisti www.lyfis.is
Ritrýnt efni
75. Cuijpers P, Dekker J, Hollon SD, Andersson G. Adding psychotherapy to pharmacotherapy in the treatment of depressive disorders in adults: a meta-analysis. The Journal of clinical psychiatry 2009;70:1219-29.
99. Martin JLR, Barbanoj MJ, Schlaepfer TE, Thompson E, Pérez V, Kulisevsky J. Repetitive transcranial magnetic stimulation for the treatment of depression. The British Journal of Psychiatry 2003;182:480-91.
